4/A//SEC Filing
Kim Lorence H. 4/A
Accession 0001610717-24-000376
CIK 0001628171other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 5:07 PM ET
Size
7.1 KB
Accession
0001610717-24-000376
Insider Transaction Report
Form 4/AAmended
Kim Lorence H.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20+15,955→ 15,955 totalExercise: $37.54Exp: 2034-06-19→ Common Stock (15,955 underlying) - Award
Common Stock
2024-06-20+4,248→ 69,948 total
Footnotes (2)
- [F1]Includes 8,623 restricted stock units ("RSUs").
- [F2]Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001643746
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 5:07 PM ET
- Size
- 7.1 KB